MedPath

Role of drug Tagaradi kwath in the management of Anidra (Insomnia)

Phase 4
Conditions
Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
Registration Number
CTRI/2021/09/036371
Lead Sponsor
Self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patient of Anidra suffering upto 3 months of duration.

2)Nidranasha(Insomnia) according to Athens Insomnia Scale.

3)Patient without any complication of other disease will include in this study.

Exclusion Criteria

1)Anidra due to other conditions such as madatyaya,abhighata and othervsystemic diseases.

2)Patients on hypnotic medicine or other drugs known to cause drowsiness.

3)Patients with acute illness like myocardial infraction, congestive cardiac failure,COPD,meningitis,acute pain condition and similar other disease.

4)Patients with major psychiatric illness like epilepsy,schizophrenia,major depressive psychosis etc.

5)Patients having chronic disease like liver cirrhosis,asthma,malignancies,diabetes,hypertension and chronic renal failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Relief in Angmarda <br/ ><br>2)Relief in Sirogaurava <br/ ><br>3)Relief in jrumbha <br/ ><br>4)Relief in jadyata <br/ ><br>5)Relief in bhrama <br/ ><br>6)Relief in tandraTimepoint: 45th day
Secondary Outcome Measures
NameTimeMethod
nillTimepoint: nill
© Copyright 2025. All Rights Reserved by MedPath